| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.051 | 0.3 |